CompletedNot Applicable

Modified Interactive Screening Program Plus MINDBODYSTRONG: A Mental Health Resiliency Intervention for Nurses

United States849 participantsStarted 2023-04-17

Plain-language summary

The overall purpose of this study is to evaluate the efficacy of an intervention designed to prevent nurse suicide. This randomized controlled trial will test the modified Interactive Screening Program (mISP) alone and the mISP combined with a program called MINDBODYSTRONG. The mISP is a method of screening to detect clinicians at moderate to high risk for suicide and referring them for treatment through an encrypted anonymous on-line platform. MINDBODYSTRONG© is an adaptation of a well-tested cognitive-behavioral skills building intervention (also known as COPE in the literature) that provides a cognitive-behavior theory-based approach to decrease depression, anxiety and suicidal ideation and improve healthy lifestyle beliefs and behaviors in at-risk populations. MINDBODYSTRONG© will involve eight self-paced computerized sessions designed specifically for nurses and clinicians. Nurses will be recruited nationally through the professional nursing organizations and health systems.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * self-identify as a registered nurse * identified as moderate to high risk of suicide by the mISP-specific interactive screening program assignment Exclusion Criteria: * low risk of suicide by the mISP-specific interactive screening program assignment * under the age of 18 years * prior participation in MINDBODYSTRONG * prior participation in this study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1This trial focused specifically on nurses experiencing burnout, depression, and suicidal thoughts — if I'm a nurse (or healthcare worker) dealing with these issues, is this kind of combined mental health resiliency program something you'd recommend I look into, or are there similar evidence-based programs already available to me?
2Since this trial is now completed and was measuring changes in suicidal intent and depressive symptoms, has the results data been published yet, and could you help me understand what it found about whether the MINDBODYSTRONG program actually reduced those symptoms?
3This study combined an interactive screening program with a resiliency intervention called MINDBODYSTRONG — are there any comparable programs or resources already accessible at our hospital or through my employer that work in a similar way?
4Because this trial is marked as Phase NA, meaning it wasn't testing a drug or device but rather a behavioral program, what does that mean for how confident we can be about the safety and effectiveness of this type of intervention compared to more traditional clinical trials?
5If I'm struggling with burnout or depressive symptoms right now, would it make more sense to start with standard treatment options immediately rather than waiting to see if a program like this becomes more widely available based on the trial's results?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change is being assessed for an increase or decrease in self-reported suicidal intent

Timeframe: Baseline (Timepoint 0), 8 weeks after baseline (Timepoint 1), 3 months after screening (Timepoint 2), 6 months after screening (Timepoint 3), 12 months after screening (Timepoint 4)

Change in is being assessed for an increase or decrease in self-reported depressive symptoms

Timeframe: Baseline (Timepoint 0), 8 weeks after baseline (Timepoint 1), 3 months after screening (Timepoint 2), 6 months after screening (Timepoint 3), 12 months after screening (Timepoint 4)

Trial details

NCT IDNCT05582343

SponsorOhio State University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-10

View on ClinicalTrials.gov More Suicide Threat trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change is being assessed for an increase or decrease in self-reported suicidal intent

Timeframe: Baseline (Timepoint 0), 8 weeks after baseline (Timepoint 1), 3 months after screening (Timepoint 2), 6 months after screening (Timepoint 3), 12 months after screening (Timepoint 4)

Change in is being assessed for an increase or decrease in self-reported depressive symptoms

Timeframe: Baseline (Timepoint 0), 8 weeks after baseline (Timepoint 1), 3 months after screening (Timepoint 2), 6 months after screening (Timepoint 3), 12 months after screening (Timepoint 4)